European Archives - Page 962 of 1138 - European Medical Journal

Long-Term Eczema May be Triggered by Immune System Over-reaction

MATHEMATICAL MODELLING has been used to study how atopic dermatitis (AD), the most common form of eczema, progresses. A team of researchers from Imperial…

New Cavity Treatment Allows Tooth to Repair Itself

SCIENTISTS from the Dental Institute at King’s College London, London, UK, have reported a way to stimulate stem cell renewal as a new tooth repair…

Musical Anhedonia Linked to Reward Responses

SPECIFIC musical anhedonia, or an inability to experience pleasure from music, has been associated with a reduction in the activity of an area of the..

Importance of Dietary Fibre for Gut Microbes

NEW research has emphasised the importance of dietary fibre in protecting the gut from infection, a component recommended as an integral constituent of a…

Diet Found to Influence Gene Expression

GENE expression is affected by gut microbiota changes induced by diet, new research has revealed. It is currently known that while the DNA composition of…

EMJ

Getting Real-World Data from the Salford Lung Study

…The findings of the study showed that patients with chronic obstructive pulmonary disease (COPD) who received the drug Relvar…

Awardees of Global Health Research Fund Will Tackle Disease and Infection Around the World

THE FIRST PHASE of awards for the £1.5 billion Global Challenges Research Fund (GCRF) has been announced with a focus on funding projects that will…

Depression in Cancer Patients Leads to Worse Treatment Outcomes

DEPRESSION can lead to a poorer prognosis in cancer patients as a result of the decreased amounts of brain-derived neurotrophic factor (BDNF) in their…

RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. In South Korea

Israel, December 14, 2016 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (TASE: RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily…

Bluebird Bio and Apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement

USA and Germany, December 15, 2016 – bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene…